FibroGen (FGEN) Tops Q4 EPS by 30c
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
FibroGen (NASDAQ: FGEN) reported Q4 EPS of $0.23, $0.30 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $108.1 million versus the consensus estimate of $72.1 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Audioeye, Inc. (AEYE) Tops Q1 EPS by 14c
- Hollysys Automation (HOLI) Misses Q3 EPS by 13c, Revenues Beat
- Finance of America (FOA) Reports Q1 Revenues of $499M
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!